锚定中部医药赛道｜2026武汉第95届 API China 原料药中间体展释放产业新势能

锚定中部医药赛道｜2026武汉第95届 API China 原料药中间体展释放产业新势能

诚邀参展｜2026 第 95 届中国（武汉）医药原料药中间体展，共拓制药产业新蓝海

Invitation for Exhibitors | The 95th China (Wuhan) Pharmaceutical API & Intermediates Exhibition 2026, Explore New Blue‑Ocean Opportunities for Pharmaceutical Industry

尊敬的医药原料药、中间体生产企业、研发机构、CRO/CDMO 服务商：Dear manufacturers, R&D institutions, CRO & CDMO service providers of pharmaceutical APIs and intermediates,

2026 年 11 月 11‑13 日，第 95 届中国国际医药原料药 / 中间体 / 包装 / 设备交易会（API China）将落地武汉国际博览中心。From November 11 to 13, 2026, the 95th China International Pharmaceutical API, Intermediates, Packaging & Equipment Fair (API China) will be held at Wuhan International Expo Center.

依托武汉华中医药核心区位优势，展会总规模 80000㎡，汇聚 2000 + 海内外展商，邀约 120000 + 专业观众，覆盖制剂工厂、制药集团、贸易商、海外采购商、研发机构，辐射国内中部六省并对接全球三十余个国家地区采购需求API China。Benefiting from Wuhan’s geographical advantage as central‑China’s pharmaceutical hub, the exhibition covers 80,000 ㎡ with more than 2,000 domestic and overseas exhibitors. It attracts over 120,000 professional visitors including preparation manufacturers, pharmaceutical groups, traders, overseas buyers and R&D institutes, covering six central‑China provinces and connecting purchasers from more than 30 countries and regions worldwide.

原料药与中间体专区重点面向以下企业开放参展：Exhibitor scope for API & Intermediate Zone:化学原料药、定制合成医药中间体、多肽原料药、生物发酵原料、天然动植物提取物、医药精细化工品、合成生物创新原料、中药药用原料；CRO/CDMO 定制研发、工艺开发、委托生产服务；兽药、保健品相关医药原料企业等。Chemical APIs, custom‑synthesized pharmaceutical intermediates, peptide APIs, bio‑fermentation raw materials, natural plant & animal extracts, fine pharmaceutical chemicals, synthetic‑biology materials, TCM medicinal raw materials; CRO/CDMO custom R&D, process development and contract‑manufacturing services; raw‑material enterprises for veterinary medicine and health‑care products.

参展价值 Exhibiting Value

1、直面海量精准买家，深耕华中本土市场，同时获取海外采购订单，实现内外贸同步拓展。Access massive targeted buyers, expand local market in central‑China and acquire overseas purchase orders to develop domestic & international business simultaneously.

2、与制剂企业、下游终端面对面沟通，快速收集市场反馈，推进新品工艺落地与商务合作。Face‑to‑face communication with preparation factories and downstream end‑users to collect market feedback, accelerate new‑product launch and business cooperation.

3、同期多场行业专题峰会，围绕原料药绿色生产、出口合规、合成生物产业化、中间体新工艺开展研讨，把握政策与技术前沿动向。Numerous parallel‑session forums focus on green production of APIs, export compliance, synthetic‑biology industrialization and new intermediate technologies, helping enterprises grasp policy updates and technical trends.

4、与药用辅料、医药包装、制药设备展区同馆联动，完整覆盖制药全产业链，挖掘跨领域合作机会。Co‑located with pharmaceutical excipient, pharmaceutical packaging and pharma‑equipment pavilions to form a complete pharmaceutical industrial chain and tap cross‑field cooperation chances.

5、组委会全媒体矩阵推广，行业媒体、垂直平台、定向邀约、海外渠道同步宣发，提升企业品牌曝光度。Organizer’s multi‑channel promotion including industry media, vertical platforms, targeted invitation and overseas publicity maximizes brand exposure for exhibitors.

目前展位预订工作正式启动，黄金展位资源紧俏。欢迎各企业咨询展位方案，入驻第 95 届 API China 武汉展，共享 2026 年末医药产业商贸红利。Booth booking is now open with limited premium booths available. Enterprises are welcome to inquire about booth solutions and join API China 2026 Wuhan to share year‑end business dividends of pharmaceutical sector.